dihexa cancer risk hgf c met Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk | Cell International dihexa hgf c-met cancer risk
dihexa hgf c met cancer risk HGF c MET pathway in cancer: from molecular characterization to clinical evidence Targeted Inhibition of Hepatocyte Growth c Met Signaling as a Therapeutic Target in Head : The Cancer Journal Targeting HGF c MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion Cell Communication and Signaling Springer Nature Link Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress
Pay in 4 interest-free payments of $5.15 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17


